Pharma news
Pharma
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided. 25 August 2022
Pharma
Safe harbour provisions can be relied on but their boundaries are still being defined, explain Jeanna Wacker and Tasha Francis Gerasimow of Kirkland & Ellis. 25 August 2022
Americas
New Jersey court dismissed a suit regarding an oral antibiotic | Prior art invalidated plaintiff’s four patents. 18 August 2022
Pharma
Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP. 16 August 2022
Americas
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision. 16 August 2022
Americas
Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff. 10 August 2022
Americas
Pharma giant to acquire biopharma firm specialising in sickle cell treatment | Key treatment will be distributed to countries most impacted by the disease. 9 August 2022
Pharma
Pharma company to acquire biopharma focused on autoimmune, inflammatory and cancer therapeutics / Deal includes acquisition of Tavneos / Spate of acquisitions follows increased competition. 8 August 2022
Pharma
Pharma firm joins with patent pool to expand access to HIV treatment | 90 countries set to benefit from preventative medicine 29 July 2022
Pharma
German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats. 28 July 2022